Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunotherapy, Active”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07584954
What this trial is testing

Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors

Who this might be right for
Solid Tumor CancerSolid Tumor Cancer Treatment With Immunotherapy
Jun Zhou 90
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Early research (Phase 1)Study completedNCT01032681
What this trial is testing

EMD 521873 in Advanced Solid Tumors, MTD Finding

Who this might be right for
Non-Hodgkin Lymphoma
Merck KGaA, Darmstadt, Germany 66
Early research (Phase 1)Study completedNCT00052182
What this trial is testing

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Temporarily pausedNCT06888323
What this trial is testing

Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment

Who this might be right for
Refractory Myelodysplastic Syndrome
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT02950259
What this trial is testing

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

Who this might be right for
Breast NeoplasmBreast Neoplasm, MaleTriple Negative Breast Cancer
Providence Health & Services 16
Testing effectiveness (Phase 2)Study completedNCT01516593
What this trial is testing

Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma

Who this might be right for
HIVBurkitt's Lymphoma
Andres J. M. Ferreri 19
Testing effectiveness (Phase 2)Study completedNCT02137746
What this trial is testing

Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
SOTIO a.s. 24
Testing effectiveness (Phase 2)Study completedNCT01430117
What this trial is testing

Biological Standardization of Poa Pratensis Allergen Extract

Who this might be right for
Allergy to Grass Pollen
Laboratorios Leti, S.L. 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738341
What this trial is testing

GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)
Eddingpharm (Zhuhai) Co., Ltd. 270
Testing effectiveness (Phase 2)Study completedNCT03633110
What this trial is testing

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

Who this might be right for
Cutaneous MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Genocea Biosciences, Inc. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07574541
What this trial is testing

Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance

Who this might be right for
AdenocarcinomaProstate CancerNeoplasms+3 more
National Cancer Institute (NCI) 52
Testing effectiveness (Phase 2)Ended earlyNCT03681951
What this trial is testing

First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors

Who this might be right for
Neoplasms, Pancreatic
GlaxoSmithKline 8
Testing effectiveness (Phase 2)Study completedNCT00012064
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma

Who this might be right for
Melanoma (Skin)
Lisata Therapeutics, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT00381212
What this trial is testing

A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent.

Who this might be right for
HIV SeropositivityAcquired Immunodeficiency Syndrome
McGill University Health Centre/Research Institute of the McGill University Health Centre 10
Not applicableUnknownNCT06506396
What this trial is testing

Rehabilitation Needs for Hematologic Cancer Candidate for Hematopoietic Stem Cell Transplantation or CAR T-Cell Therapy

Who this might be right for
Stem Cell TransplantationImmunotherapyCAR T-Cell Therapy
University of Modena and Reggio Emilia 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02519348
What this trial is testing

Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
MedImmune LLC 433
Testing effectiveness (Phase 2)Study completedNCT00431561
What this trial is testing

Phase IIb Clinical Trial With TGF-β2 Antisense Compound AP 12009 for Recurrent or Refractory High-grade Glioma

Who this might be right for
GlioblastomaAnaplastic Astrocytoma
Isarna Therapeutics GmbH 141
Not applicableWithdrawnNCT06610097
What this trial is testing

TNBC Gut Microbiota During Neoadjuvant Treatment

Who this might be right for
Breast CancerTriple Negative Breast CancerEarly Stage Triple-Negative Breast Carcinoma
Scripps Health
Testing effectiveness (Phase 2)WithdrawnNCT04046107
What this trial is testing

Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

Who this might be right for
Hepatitis B Virus
National Institute of Allergy and Infectious Diseases (NIAID)
Next Page